CHGCY OTC
Chugai Pharmaceutical Co., Ltd.
1W: -9.5%
1M: -11.7%
3M: -18.0%
YTD: -27.7%
1Y: -17.4%
3Y: +32.7%
5Y: +4.7%
$19.08
-0.25 (-1.29%)
Weekly Expected Move ±4.5%
$17
$18
$19
$20
$21
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$408.3B
-8.8% ▼
5Y CAGR: +14.8%
Capital Expenditures
$80.0B
-45.7% ▼
5Y CAGR: +5.4%
Free Cash Flow
$328.4B
-16.4% ▼
5Y CAGR: +18.0%
Dividends Paid
$313.9B
-135.6% ▼
Buybacks
$6M
+37.1% ▲
Net Change in Cash
-$112.3B
-237.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $470.4B | $575.9B | $325.5B | $589.5B | $455.1B |
| Depreciation & Amort. | $30.9B | $31.4B | $0 | $0 | $34.1B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$83.1B | -$183.3B | $130.6B | -$28.8B | -$83.5B |
| Other Non-Cash Items | -$138.5B | -$179.9B | $17.6B | -$113.1B | $2.7B |
| Operating Cash Flow | $279.6B | $244.1B | $409.9B | $447.6B | $408.3B |
| — Investing Activities — | |||||
| Capital Expenditures | -$72.9B | -$71.2B | -$71.9B | -$50.9B | -$117.0B |
| Acquisitions (Net) | $6.9B | $1.0B | $0 | $0 | $7.9B |
| Investment Purchases | -$372.3B | -$519.0B | -$546.0B | -$948.6B | -$1.29T |
| Investment Sales | $325.0B | $442.9B | $547.0B | $771.0B | $1.19T |
| Other Investing | -$5.7B | $280M | $33.7B | $1.1B | $30M |
| Investing Cash Flow | -$118.9B | -$146.0B | -$37.3B | -$227.4B | -$214.8B |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | -$8M | -$5M | -$5M | -$10M | -$6M |
| Dividends Paid | -$98.6B | -$138.2B | -$131.6B | -$133.2B | -$313.9B |
| Other Financing | -$8.8B | -$7.7B | -$7.9B | -$7.9B | -$8.6B |
| Financing Cash Flow | -$107.4B | -$145.6B | -$139.3B | -$141.0B | -$322.4B |
| Net Change in Cash | $55.4B | -$45.6B | $236.5B | $81.5B | -$112.3B |
| Cash End of Period | $267.8B | $222.2B | $458.7B | $540.2B | $426.9B |
| Free Cash Flow | $206.8B | $172.9B | $335.7B | $392.7B | $328.4B |